| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-06 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-06 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-06 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.18 | 1e-06 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-06 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-06 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.18 | 4e-06 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.29 | 4e-06 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-06 |